08/29/2025 3:26 PM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
08/29/2025 3:28 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
08/28/2025 7:00 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2025 9:03 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2025 5:22 PM | Khan Najat (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2025 5:22 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2025 5:22 PM | Recursion Pharmaceuticals (Issuer) Taylor Ben R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2025 2:18 PM | Khan Najat (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2025 8:03 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2025 2:31 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2025 5:33 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for RXRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
08/05/2025 5:31 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2025 7:14 AM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
07/08/2025 7:19 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2025 2:30 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2025 2:30 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:22 PM | Recursion Pharmaceuticals (Issuer) Sun Elaine D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:22 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:23 PM | Bumpus Namandje (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:23 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:23 PM | HERSHBERG ROBERT (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:23 PM | Michor Franziska (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:23 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2025 3:32 PM | Recursion Pharmaceuticals (Issuer) Taylor Ben R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2025 3:22 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2025 5:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2025 4:26 PM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
05/09/2025 4:27 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/05/2025 5:07 AM | Recursion Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/05/2025 5:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/05/2025 5:02 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/03/2025 3:37 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:37 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:38 PM | Recursion Pharmaceuticals (Issuer) Taylor Ben R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2025 3:52 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2025 11:02 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 3:25 PM | Recursion Pharmaceuticals (Issuer) Sun Elaine D (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/19/2025 3:26 PM | Bumpus Namandje (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/19/2025 3:27 PM | Recursion Pharmaceuticals (Issuer) Sun Elaine D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 3:27 PM | Bumpus Namandje (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 3:27 PM | Recursion Pharmaceuticals (Issuer) Taylor Ben R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad) A new set of 7 AI stocks are DOMINATING the market.
Here’s why one financial guru says they could be the most famous companies in the world by 2030. Check this Out (The NEXT Magnificent Seven) |
03/18/2025 7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2025 3:16 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 10:55 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025 9:13 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025 6:26 AM | Recursion Pharmaceuticals (Filer)
| Form 424B5 | |
02/28/2025 5:31 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2025 5:33 AM | Recursion Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/20/2025 3:42 PM | Recursion Pharmaceuticals (Issuer) Taylor Ben R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 3:42 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:41 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:23 AM | ARK Investment Management LLC (Filed by) Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025 4:07 PM | Recursion Pharmaceuticals (Filer)
| Form S-3ASR | |
02/12/2025 8:32 AM | BAILLIE GIFFORD & CO (Filed by) Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025 9:40 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025 4:28 PM | BlackRock, Inc. (Filed by) Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025 8:44 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025 3:13 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025 4:09 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025 3:12 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025 3:21 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 4:26 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 8:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 9:58 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025 9:30 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025 5:02 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 5:02 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 5:02 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 3:24 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024 3:16 PM | Recursion Pharmaceuticals (Issuer) Taylor Ben R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 5:49 PM | Recursion Pharmaceuticals (Issuer) Taylor Ben R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 4:05 PM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
12/17/2024 4:06 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2024 3:48 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 4:46 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 9:29 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2024 9:32 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 3:40 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/02/2024 6:02 PM | Recursion Pharmaceuticals (Issuer) Taylor Ben R (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/27/2024 3:09 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
11/26/2024 3:48 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
11/22/2024 5:25 PM | Michor Franziska (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/22/2024 5:25 PM | Michor Franziska (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 6:11 AM | Recursion Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2024 6:14 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/19/2024 5:26 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 5:26 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 5:26 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 5:26 PM | Mauro David J (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2024 5:52 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 6:19 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
One tiny company just cracked Google’s $19B problem (Ad) For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production.
Then an MIT team cracked the code… dropping the cost from $63,000 to just 90 cents per gram.
Now, one US-based factory is gearing up to supply the AI, aerospace, and EV industries with the one material they can’t continue to grow without.
Only one company controls it, and its stock is still flying under Main Street’s radar. See why the race for supply has already started. |
11/14/2024 6:19 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2024 3:34 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024 9:11 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024 8:22 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 3:57 PM | Recursion Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024 1:48 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024 9:34 AM | FMR LLC (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024 1:17 PM | BlackRock, Inc. (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024 3:18 PM | Recursion Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |